North America Molecular Cytogenetics Market 2021 Trends Top Manufactures and Industry Growth Analysis
North America Molecular Cytogenetics Market By Product (Kit, Reagent, Probe, Consumable, Software, Service)
(EMAILWIRE.COM, December 16, 2017 ) The North America Molecular Cytogenetics market size was approx. USD 530 million in 2016. It is projected to grow at a CAGR of 10.5 % to reach USD 870 million by 2021. It commands the largest market share of 34%.
Two primary fields which are studied under molecular cytogenetics are Molecular biology and cytogenetics. Cytogenetics is termed as the study of chromosomes.
Browse more details @ http://marketdataforecast.com/market-reports/north-america-molecular-cytogenetics-market-3224/
The North America Molecular Cytogenetics market can be categorized into four categories: by product, by technique, by application and by end user. On the basis of product, North America Molecular Cytogenetics market is classified into Kits & Reagents, Instruments, Consumables, and Software & Services. Kits and Reagents is further segmented into Testing Kits, Probes, Fluorescent Affinity Reagents and Other Kits & Reagents. If we go by technique, North America Molecular Cytogenetics market is segmented into Comparative Genomic Hybridization, Fluorescence in Situ Hybridization, In Situ Hybridization, and Other Techniques. The CGH technology category commands the largest market share of approximately 53% and is estimated to retain its leading position over the aforementioned forecast period.
Rising cases of various types of cancer coupled with the rising demand for high-throughput diagnostic tools is expected to boost the usage rate of the molecular cytogenetic technologies over the aforementioned forecast period. Personalized medicine segment is poised to widen the therapeutic horizons in delivering enhanced, molecularly guided therapies, and precise monitoring of disease progression thereby leading to the growth of this market segment. Last but not the least, on the basis of end user the market is segmented into Clinical & Research Laboratories, Academic Research Institutes, Pharmaceutical & Biotechnology Companies and Other End Users.
Download Free Sample Report @ http://marketdataforecast.com/market-reports/north-america-molecular-cytogenetics-market-3224/request-sample
By geography, the North America Molecular Cytogenetics market has been categorized into US and Canada. Presently, North America accounts for the largest market share. It can be attributed to the rising incidences of cancer and increasing number of genetic disorders. It is especially nasty towards the infant population because they are susceptible to the environmental factors such as teratogens. Apart from that, implementation of advanced molecular cytogenetic techniques, for example, FISH and array-comparative genomic hybridization (array-CGH) for early as well as timely detection of diseases along with reducing the mortality rate and the grievous consequences associated with genetic disorders.
Affymetrix, Inc., Agilent Technologies, Inc., Illumina, Inc., Abbott Laboratories, Bio-Rad Laboratories, Inc., Applied Spectral Imaging, Inc., and Thermo Fisher Scientific (Life Technologies), Inc. are some major players operating in the molecular cytogenetics market.
Table of Contents:
1.Introduction
Market Definition
Study Deliverables
Base Currency, Base Year and Forecast Periods
General Study Assumptions
2. Research Methodology
Introduction
Research Phases
Analysis Design
Study Timeline
3. Overview
Executive Summary
Key Inferences
Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
Market Drivers
Market Restraints
Key Challenges
Current Opportunities in the Market
5. Market Segmentation
Product
Technique
Application
End User
6. Geographical Analysis
Introduction
United States
Canada
7.Strategic Analysis
PESTLE analysis
Porter’s Five analysis
8.Market Leaders' Analysis
F. Hoffmann-La Roche Ltd. (Switzerland)
Danaher Corporation (U.S.)
Thermo Fisher Scientific Inc. (U.S.)
Abbott Laboratories (U.S.)
Agilent Technologies (U.S.)
PerkinElmer, Inc. (U.S.)
Illumina, Inc. (U.S.)
Bio-Rad Laboratories (U.S.)
Oxford Gene Technology (U.K.)
Applied Spectral Imaging (U.S.)
9.Competitive Landscape
Market share analysis
Merger and Acquisition Analysis
Agreements, collaborations and Joint Ventures
New Product Launches
10.Market Outlook and Investment Opportunities
Inquire before buying @ http://marketdataforecast.com/market-reports/north-america-molecular-cytogenetics-market-3224/inquire
About us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialties with competitive pricing options.
For more information, kindly visit, www.marketdataforecast.com
Two primary fields which are studied under molecular cytogenetics are Molecular biology and cytogenetics. Cytogenetics is termed as the study of chromosomes.
Browse more details @ http://marketdataforecast.com/market-reports/north-america-molecular-cytogenetics-market-3224/
The North America Molecular Cytogenetics market can be categorized into four categories: by product, by technique, by application and by end user. On the basis of product, North America Molecular Cytogenetics market is classified into Kits & Reagents, Instruments, Consumables, and Software & Services. Kits and Reagents is further segmented into Testing Kits, Probes, Fluorescent Affinity Reagents and Other Kits & Reagents. If we go by technique, North America Molecular Cytogenetics market is segmented into Comparative Genomic Hybridization, Fluorescence in Situ Hybridization, In Situ Hybridization, and Other Techniques. The CGH technology category commands the largest market share of approximately 53% and is estimated to retain its leading position over the aforementioned forecast period.
Rising cases of various types of cancer coupled with the rising demand for high-throughput diagnostic tools is expected to boost the usage rate of the molecular cytogenetic technologies over the aforementioned forecast period. Personalized medicine segment is poised to widen the therapeutic horizons in delivering enhanced, molecularly guided therapies, and precise monitoring of disease progression thereby leading to the growth of this market segment. Last but not the least, on the basis of end user the market is segmented into Clinical & Research Laboratories, Academic Research Institutes, Pharmaceutical & Biotechnology Companies and Other End Users.
Download Free Sample Report @ http://marketdataforecast.com/market-reports/north-america-molecular-cytogenetics-market-3224/request-sample
By geography, the North America Molecular Cytogenetics market has been categorized into US and Canada. Presently, North America accounts for the largest market share. It can be attributed to the rising incidences of cancer and increasing number of genetic disorders. It is especially nasty towards the infant population because they are susceptible to the environmental factors such as teratogens. Apart from that, implementation of advanced molecular cytogenetic techniques, for example, FISH and array-comparative genomic hybridization (array-CGH) for early as well as timely detection of diseases along with reducing the mortality rate and the grievous consequences associated with genetic disorders.
Affymetrix, Inc., Agilent Technologies, Inc., Illumina, Inc., Abbott Laboratories, Bio-Rad Laboratories, Inc., Applied Spectral Imaging, Inc., and Thermo Fisher Scientific (Life Technologies), Inc. are some major players operating in the molecular cytogenetics market.
Table of Contents:
1.Introduction
Market Definition
Study Deliverables
Base Currency, Base Year and Forecast Periods
General Study Assumptions
2. Research Methodology
Introduction
Research Phases
Analysis Design
Study Timeline
3. Overview
Executive Summary
Key Inferences
Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
Market Drivers
Market Restraints
Key Challenges
Current Opportunities in the Market
5. Market Segmentation
Product
Technique
Application
End User
6. Geographical Analysis
Introduction
United States
Canada
7.Strategic Analysis
PESTLE analysis
Porter’s Five analysis
8.Market Leaders' Analysis
F. Hoffmann-La Roche Ltd. (Switzerland)
Danaher Corporation (U.S.)
Thermo Fisher Scientific Inc. (U.S.)
Abbott Laboratories (U.S.)
Agilent Technologies (U.S.)
PerkinElmer, Inc. (U.S.)
Illumina, Inc. (U.S.)
Bio-Rad Laboratories (U.S.)
Oxford Gene Technology (U.K.)
Applied Spectral Imaging (U.S.)
9.Competitive Landscape
Market share analysis
Merger and Acquisition Analysis
Agreements, collaborations and Joint Ventures
New Product Launches
10.Market Outlook and Investment Opportunities
Inquire before buying @ http://marketdataforecast.com/market-reports/north-america-molecular-cytogenetics-market-3224/inquire
About us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialties with competitive pricing options.
For more information, kindly visit, www.marketdataforecast.com
Contact Information:
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results